 |
3 Products |  |
36 Diseases | | 3 Products |
|
4 Trials |  |
668 News |  |
| «123456» |
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Aviptadil aka RLF-100 had perfect results but EUA was declined 2x: https://t.co/T1z2rae9w4 (Twitter) - Oct 7, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Biomarker: Deeming therapies as futile for missing a pre-specified primary endpoint, in the context of a rapidly mutating virus and evolving SOC, when important biomarkers are significantly improved, has failed our country miserably (led to x00,000s unnecessary deaths). #aviptadil (Twitter) - Oct 4, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Good target…vasoactive intestinal peptide does the same thing and was identified 2 years ago as a treatment. Synthetic version (aviptadil/zyesami) has received approval in India, but was deemed futile in an NIH trial, in spite of earlier studies that showed IL6 and oxygenation (Twitter) - Sep 30, 2022
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx, Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
Clinical protocol, Journal: Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. (Pubmed Central) - Sep 29, 2022
P2
In the context of upcoming new variants of SARS-CoV-2 and possible inefficacy of the available vaccines and antibody therapies, the investigation of alternative therapy options plays a crucial role in decreasing associated mortality and improving prognosis. Due to its unique immunomodulating properties also targeting the SARS-CoV-2 pathways, inhaled aviptadil may have the potential to prevent ARDS in COVID-19.
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
So in the absence of adequate antivirals, you must protect the ace2 cells. Is what this study reveals actually the virus disrupting ace2/vasoactive intestinal peptide in the pancreas? (As the virus does in the lungs?) #aviptadil https://t.co/WOU2tXAupW (Twitter) - Sep 25, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Drugs like aviptadil should be part of your tool chest. Period. The NIH’s Tesico trial was a colossal waste of taxpayer money, if we didn’t learn why aviptadil had such a dramatic effect on lung health within the first 7-14 days following a 3 day treatment cycle. (Twitter) - Sep 7, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Why did the NIH apply different primary endpoints to Activ3b and Activ3? Recovery, assessed at 90 days for aviptadil vs Sustained recovery defined as being discharged from the index hospitalization, followed by being alive and home for 14 consecutive days prior to Day 90. (Twitter) - Sep 6, 2022
- ||||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Your visual is so impactful. The reverse has also been seen with aviptadil administered to critical covid patients. Have you seen any of the work Dr. Youssef did at Houston Methodist? https://t.co/oviY1Gbwjg (Twitter) - Sep 4, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx, Paxlovid (nirmatrelvir and ritonavir) / Pfizer
Clinical: If true that patients are dying in varying ways from omicron, then shouldn’t our medical community have access to aviptadil, that improves oxygenation, for those patients that need it? (Just like paxlovid may work for a subset of covid patients, but not all.) (Twitter) - Aug 25, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Dr. Hotez, can you address what happened to aviptadil? Why was it subjected to such extreme endpoints in the NIH’s Tesico trial versus the drugs that were trialed in Activ-3? We still have limited options for critical covid and ~400 per day dying. (Twitter) - Aug 25, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Aviptadil does what it should…as proven in India and now Saudi Arabia with detailed, transparent trials/results. NIH assigned unprecedented, and in ways, irrelevant endpoints in its study of aviptadil. How did oxygenation change in the Tesico trial? Will the world ever know? (Twitter) - Aug 20, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Aviptadil works. https://t.co/geQ7YIky3k (Twitter) - Aug 18, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
Enrollment change, Trial withdrawal: AVICOVID-2: Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 (clinicaltrials.gov) - Aug 1, 2022
P3, N=0, Withdrawn, Sponsor: NeuroRx, Inc.
Due to its unique immunomodulating properties also targeting the SARS-CoV-2 pathways, inhaled aviptadil may have the potential to prevent ARDS in COVID-19. N=498 --> 0 | Not yet recruiting --> Withdrawn
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
Trial completion date, Trial primary completion date: Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS (clinicaltrials.gov) - Jun 23, 2022
P2, N=82, Recruiting, Sponsor: Prof. Dr. J
N=498 --> 0 | Not yet recruiting --> Withdrawn Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Mar 2022 --> Nov 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Too little too late Punt having milked Wuhan-1 dry Likely lag will widen officially denied transmission accelerating variants Milk BA1 Vax propped by ridiculous numbers-study duration a wink as RLF100 scuttled IFn inducers or dummy virus decoys lip served & nature equilibrates 🕴🏿 (Twitter) - Jun 9, 2022
- ||||| Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
Enrollment closed: TESICO: ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 (clinicaltrials.gov) - Jun 3, 2022
P3, N=640, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial completion date: Apr 2022 --> Dec 2022 | Trial primary completion date: Mar 2022 --> Nov 2022 Recruiting --> Active, not recruiting
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#aviptadil is what we need (Twitter) - May 29, 2022
- | Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#rlftf #rlfty #aviptadil #acer (Twitter) - May 25, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#aviptadil is safe and effective #NIH (Twitter) - May 24, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Russia and China will have #Aviptadil available for their people dying from Covid, via India and the BRICS alliance, while the FDA delays it for Americans. Unbelievable! (Twitter) - May 21, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical, P2 data: Treatments like AVIPTADIL have been around for decades and work for this indication. since it’s not big pharma they get no love. Big pharma owns our FDA; thought it might be the case pre-pandemic / now I would never invest in a small company with solid phase 2 data. (Twitter) - May 20, 2022
- Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
Simultaneous Lung and Kidney Transplant in a Young Patient with COVID-19 (Hynes Halls C & D: Board No. C280) - May 20, 2022 - Abstract #ATC2022ATC_3303;
Despite treatment with Remdesivir and dexamethasone, the patient developed hypoxemic respiratory failure with acute renal injury requiring ICU care and intubation, V-V ECMO, and dialysis. We propose that SLK transplantation should be considered for carefully selected patients with COVID-19 ARDS.
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#Aviptadil (Twitter) - May 20, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Russia and China will have #Aviptadil available for their people dying from Covid, via India and the BRICS alliance, while the FDA delays it for Americans. Unbelievable! (Twitter) - May 20, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Russia and China will have #Aviptadil available for their people dying from Covid, via India and the BRICS alliance, while the FDA delays it for Americans. Unbelievable! (Twitter) - May 20, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#Aviptadil proven safe and effective (Twitter) - May 19, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#Aviptadil (Twitter) - May 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
FDA event: @DrWoodcockFDA @YoDoctorYo @POTUS @besthof_robert @DrCaliff_FDA Aviptadil was granted EUA in India on 29 April 2022. WTAF is the FDA waiting for here in the US? 2-Million deaths? Why isn't it approved in the US? Life is important. right to try https://t.co/I17MlgbNq9 (Twitter) - May 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
FDA event: @DrWoodcockFDA @YoDoctorYo @POTUS @besthof_robert @DrCaliff_FDA Aviptadil was granted EUA in India on 29 April 2022. WTAF is the FDA waiting for here in the US? 2-Million deaths? Why isn't it approved in the US? Life is important. right to try https://t.co/I17MlgbNq9 (Twitter) - May 19, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
FDA event: India approved #aviptadil for those dying from Covid while the FDA delays it for Americans. Unbelievable! (Twitter) - May 18, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#Aviptadil Proven to be safe and effective (Twitter) - May 18, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
#Aviptadil (Twitter) - May 18, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Wait until the country learns how long #Aviptadil could of been available to save those dying from Covid. Mind bending! (Twitter) - May 15, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
It’s tragic the #Aviptadil is still not readily available for those still dying from Covid. Absolute craziness ! (Twitter) - May 15, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
The country needs #Aviptadil to end the Covid deaths. https://t.co/q26e0GWtWm (Twitter) - May 12, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
1/2 The past two years have allowed ample time to identify and trial variant-agnostic therapeutics. Zyesami (aviptadil), a synthetic version of Vasoactive Intestinal Peptide, is being trialed by NIH for critical covid, and in Europe via inhalation, earlier. (Twitter) - May 8, 2022
- ||| remdesivir / Generic mfg., Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical, FDA event: It is proven that remdesivir is not effective for severe patients. now they approve it in children, when ZYESAMI-AVIPTADIL exists and the FDA refuses to approve it. How long are they going to keep fooling people? (Twitter) - Apr 26, 2022
- || Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Google .. Zyesami Aviptadil (Twitter) - Apr 26, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: https://t.co/kzqHH8Z8uD #ZYESAMI #AVIPTADIL @pfizer @moderna_tx @BBCBreaking @FDA_Drug_Info @ABC @FDASpox_Archive @cnnbrk @NIH @RepAndyBiggsAZ @tedcruz @US_FDA @COVIDOversight @BBCNews @bbchealth @RepChipRoy @SenTedCruz @NIH @DrWoodcockFDA @SenJohnKennedy @NIAIDNews (Twitter) - Apr 21, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: A drug ZYESAMI-AVIPTADIL existed year ago. studies show its effectiveness and safety in severely ill patients. the FDA and the government have rejected it and because of it many serious people who could have had one last chance to live, are not here today..FDA this is your fault (Twitter) - Apr 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: A drug ZYESAMI-AVIPTADIL existed year ago. studies show its effectiveness and safety in severely ill patients. the FDA and the government have rejected it and because of it many serious people who could have had one last chance to live, are not here today..FDA this is your fault (Twitter) - Apr 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: A drug ZYESAMI-AVIPTADIL existed year ago. studies show its effectiveness and safety in severely ill patients. the FDA and the government have rejected it and because of it many serious people who could have had one last chance to live, are not here today..FDA this is your fault (Twitter) - Apr 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: A drug ZYESAMI-AVIPTADIL existed year ago. studies show its effectiveness and safety in severely ill patients. the FDA and the government have rejected it and because of it many serious people who could have had one last chance to live, are not here today..FDA this is your fault (Twitter) - Apr 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: A drug ZYESAMI-AVIPTADIL existed year ago. studies show its effectiveness and safety in severely ill patients. the FDA and the government have rejected it and because of it many serious people who could have had one last chance to live, are not here today..FDA this is your fault (Twitter) - Apr 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: A drug ZYESAMI-AVIPTADIL existed year ago. studies show its effectiveness and safety in severely ill patients. the FDA and the government have rejected it and because of it many serious people who could have had one last chance to live, are not here today..FDA this is your fault (Twitter) - Apr 19, 2022
- ||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical: Getting vaccinated is very important. but the millions of lives lost were also very important, because the government and the FDA are not interested in medicines that could have saved them like ZYESAMI-AVIPTADIL, more will continue to be lost (Twitter) - Apr 19, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical, FDA event: new york covid cases and hospitalizations rises significantly. still waiting approval for ZYESAMI-AVIPTADIL, does the FDA care about therapies and medicines for seriously ill patients??? or a thousand dead daily in the US are not significant for the government? (Twitter) - Apr 15, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical, FDA event: new york covid cases and hospitalizations rises significantly. still waiting approval for ZYESAMI-AVIPTADIL, does the FDA care about therapies and medicines for seriously ill patients??? or a thousand dead daily in the US are not significant for the government? (Twitter) - Apr 15, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical, FDA event: new york covid cases and hospitalizations rises significantly. still waiting approval for ZYESAMI-AVIPTADIL, does the FDA care about therapies and medicines for seriously ill patients??? or a thousand dead daily in the US are not significant for the government? (Twitter) - Apr 15, 2022
- |||| Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NeuroRx
Clinical, FDA event: new york covid cases and hospitalizations rises significantly. still waiting approval for ZYESAMI-AVIPTADIL, does the FDA care about therapies and medicines for seriously ill patients??? or a thousand dead daily in the US are not significant for the government? (Twitter) - Apr 15, 2022